Cardinal Capital Management Inc (North Carolina)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.68M | Buy |
|
|||||
|
2025
Q2 | $2.34M | Buy |
|
|||||
|
2025
Q1 | $2.29M | Buy |
|
|||||
|
2024
Q4 | $1.99M | Buy |
|
|||||
|
2024
Q3 | $2.33M | Buy |
|
|||||
|
2024
Q2 | $2.16M | Buy |
|
|||||
|
2024
Q1 | $2.34M | Buy |
|
|||||
|
2023
Q4 | $1.86M | Buy |
|
|||||
|
2023
Q3 | $1.82M | Buy |
|
|||||
|
2023
Q2 | $1.75M | Sell |
|
|||||
|
2023
Q1 | $2.69M | Buy |
|
|||||
|
2022
Q4 | $1.11M | Buy |
|
|||||
|
2022
Q3 | $901K | Sell |
|
|||||
|
2022
Q2 | $1.74M | Buy |
|
|||||
|
2022
Q1 | $1.73M | Buy |
|
|||||
|
2021
Q4 | $1.68M | Sell |
|
|||||
|
2021
Q3 | $1.46M | Sell |
|
|||||
|
2021
Q2 | $1.92M | Buy |
|
|||||
|
2021
Q1 | $841K | Buy |
|
|||||
|
2020
Q4 | $805K | Buy |
|
|||||
|
2020
Q3 | $786K | Sell |
|
|||||
|
2020
Q2 | $878K | Sell |
|
|||||
|
2020
Q1 | $818K | Buy |
|
|||||
|
2019
Q4 | $1.01M | Sell |
|
|||||
|
2019
Q3 | $923K | Buy |
|
|||||
|
2019
Q2 | $853K | Buy |
|
|||||
|
2019
Q1 | $887K | Buy |
|
|||||
|
2018
Q4 | $802K | Buy |
|